Investment Strategy

The Fund's Strategy

  • Investing in projects focused on the Russian market with the potential for commercialization in the global market.
  • Investing in pre-seed and seed projects/companies, capitalizing investments in an efficient way.
  • Investing in projects containing intellectual property that creates natural barriers to competition.
  • Funds are only invested in pre-seed and seed companies (RUB 15 mln. per company maximum).

Priority is given to young companies operating in the following areas of life sciences:

  • Pharmaceutical technology,
  • Cell technology,
  • Genomic technology,
  • Agrobiotechnology,
  • Neurotechnology,
  • Bioengineering,
  • Medical Equipment,
  • Projects at the intersection of biological/medical and IT technologies.